vs
Side-by-side financial comparison of GOLD RESOURCE CORP (GORO) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.
RIGEL PHARMACEUTICALS INC is the larger business by last-quarter revenue ($69.8M vs $51.3M, roughly 1.4× GOLD RESOURCE CORP). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 35.1%, a 348.9% gap on every dollar of revenue. On growth, GOLD RESOURCE CORP posted the faster year-over-year revenue change (295.5% vs 21.2%). Over the past eight quarters, GOLD RESOURCE CORP's revenue compounded faster (65.6% CAGR vs 53.7%).
Gold Springs Resource Corp is a Canadian company that is pursuing the development of the Gold Springs gold-silver mine on the border of Utah and Nevada in the United States. Headquartered in Vancouver, the company is listed on the Toronto Stock Exchange in Canada and the OTCQX market exchange in the US. The company was founded in 2006 as the South American Silver Corporation, an equity carve-out of the General Minerals Corporation, to pursue exploration and development of the Malku Khota and ...
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.
GORO vs RIGL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $51.3M | $69.8M |
| Net Profit | $18.0M | $268.1M |
| Gross Margin | 51.5% | 91.5% |
| Operating Margin | 38.9% | 33.2% |
| Net Margin | 35.1% | 384.0% |
| Revenue YoY | 295.5% | 21.2% |
| Net Profit YoY | 261.6% | 1769.2% |
| EPS (diluted) | $0.14 | $14.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $51.3M | $69.8M | ||
| Q3 25 | $24.9M | $69.5M | ||
| Q2 25 | $11.2M | $101.7M | ||
| Q1 25 | $12.4M | $53.3M | ||
| Q4 24 | $13.0M | $57.6M | ||
| Q3 24 | $13.3M | $55.3M | ||
| Q2 24 | $20.8M | $36.8M | ||
| Q1 24 | $18.7M | $29.5M |
| Q4 25 | $18.0M | $268.1M | ||
| Q3 25 | $-4.7M | $27.9M | ||
| Q2 25 | $-11.5M | $59.6M | ||
| Q1 25 | $-8.3M | $11.4M | ||
| Q4 24 | $-11.1M | $14.3M | ||
| Q3 24 | $-12.7M | $12.4M | ||
| Q2 24 | $-27.0M | $-1.0M | ||
| Q1 24 | $-5.7M | $-8.2M |
| Q4 25 | 51.5% | 91.5% | ||
| Q3 25 | 25.0% | 93.2% | ||
| Q2 25 | -39.4% | 95.6% | ||
| Q1 25 | -11.8% | 91.7% | ||
| Q4 24 | -46.7% | 89.9% | ||
| Q3 24 | -65.3% | 85.5% | ||
| Q2 24 | -17.3% | 92.4% | ||
| Q1 24 | -11.6% | 93.1% |
| Q4 25 | 38.9% | 33.2% | ||
| Q3 25 | -14.9% | 40.9% | ||
| Q2 25 | -102.4% | 60.1% | ||
| Q1 25 | -63.1% | 23.9% | ||
| Q4 24 | -96.9% | 28.9% | ||
| Q3 24 | -122.7% | 25.4% | ||
| Q2 24 | -52.1% | 1.2% | ||
| Q1 24 | -40.4% | -23.6% |
| Q4 25 | 35.1% | 384.0% | ||
| Q3 25 | -18.7% | 40.2% | ||
| Q2 25 | -102.3% | 58.6% | ||
| Q1 25 | -67.3% | 21.5% | ||
| Q4 24 | -85.9% | 24.9% | ||
| Q3 24 | -95.5% | 22.5% | ||
| Q2 24 | -129.9% | -2.8% | ||
| Q1 24 | -30.4% | -27.9% |
| Q4 25 | $0.14 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.09 | $3.28 | ||
| Q1 25 | $-0.07 | $0.63 | ||
| Q4 24 | $-0.11 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.30 | $-0.06 | ||
| Q1 24 | $-0.06 | $-0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $155.0M |
| Total DebtLower is stronger | — | $52.5M |
| Stockholders' EquityBook value | $44.0M | $391.5M |
| Total Assets | $184.1M | $513.6M |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $155.0M | ||
| Q3 25 | $9.8M | $137.1M | ||
| Q2 25 | $12.7M | $108.4M | ||
| Q1 25 | $4.9M | $77.1M | ||
| Q4 24 | $1.6M | $77.3M | ||
| Q3 24 | $1.4M | $61.1M | ||
| Q2 24 | $5.3M | $49.1M | ||
| Q1 24 | $5.7M | $49.5M |
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
| Q4 25 | $44.0M | $391.5M | ||
| Q3 25 | $26.0M | $117.6M | ||
| Q2 25 | $19.2M | $81.9M | ||
| Q1 25 | $24.6M | $18.6M | ||
| Q4 24 | $27.3M | $3.3M | ||
| Q3 24 | $37.9M | $-14.6M | ||
| Q2 24 | $49.8M | $-29.9M | ||
| Q1 24 | $74.9M | $-31.7M |
| Q4 25 | $184.1M | $513.6M | ||
| Q3 25 | $164.3M | $242.5M | ||
| Q2 25 | $155.1M | $206.7M | ||
| Q1 25 | $147.7M | $176.0M | ||
| Q4 24 | $145.9M | $164.0M | ||
| Q3 24 | $154.5M | $139.4M | ||
| Q2 24 | $161.5M | $128.4M | ||
| Q1 24 | $182.8M | $126.5M |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.2M | $22.0M |
| Free Cash FlowOCF − Capex | $15.3M | — |
| FCF MarginFCF / Revenue | 29.8% | — |
| Capex IntensityCapex / Revenue | 17.3% | — |
| Cash ConversionOCF / Net Profit | 1.34× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $644.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.2M | $22.0M | ||
| Q3 25 | $-325.0K | $24.0M | ||
| Q2 25 | $-1.3M | $30.5M | ||
| Q1 25 | $-828.0K | $-893.0K | ||
| Q4 24 | $1.3M | $14.5M | ||
| Q3 24 | $-3.4M | $21.7M | ||
| Q2 24 | $-63.0K | $302.0K | ||
| Q1 24 | $1.5M | $-5.0M |
| Q4 25 | $15.3M | — | ||
| Q3 25 | $-7.8M | — | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $58.0K | — | ||
| Q3 24 | $-5.7M | — | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-512.0K | — |
| Q4 25 | 29.8% | — | ||
| Q3 25 | -31.3% | — | ||
| Q2 25 | -34.2% | — | ||
| Q1 25 | -24.4% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -43.1% | — | ||
| Q2 24 | -10.0% | — | ||
| Q1 24 | -2.7% | — |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 30.0% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 17.7% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 9.7% | — | ||
| Q1 24 | 10.7% | — |
| Q4 25 | 1.34× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
